Savita V Jayaram

Articles by Savita V Jayaram

Email : editor@ibtimes.co.in
Gilead's Remdesivir authorised for emergency use only

COVID-19 drug Remdesivir's price in India is a concern; Pharma cos free to set price

Gilead Sciences' signs non-exclusive license pact with four Indian drug majors to set their own price for Covid-19 drug Remdesivir. Following this move, many pharma distributors have been selling the experimental drug at Rs 7000 per vial. This will result in escalated treatment cost, to procure vials approximating to Rs 35,000 to Rs 42,000 for five doses. Jun 5, 2020
h1-b visa

New H-1B legislation is great news for Indians; here's why

The H-1B and L-1 Visa Reform Act was introduced in the House of Representatives and the Senate today. It directs the US Citizenship and Immigration Services (USCIS) to prioritize the annual allocation of H-1B and L-1 visas for US-educated foreign students and skilled professionals with high-wages first. May 24, 2020